DCA Officials Seize ‘Colinol-Spas Tab’ For Misleading Claim

HYDERABAD: Officials of Drugs Control Administration, Telangana seized ‘Colinol-SPAS Tablets (Mefenamic Acid and Dicyclomine Hydrochloride Tablets IP)’, an allopathic medicine, in Nampally, Hyderabad, for making a misleading advertisement claiming it treats ‘disorders of menstrual flow’.

According to DCA Director-General VB Kamalasan Reddy here on Wednesday, the officials detected a medicine ‘Colinol-SPAS Tablets’ being circulating in the market with misleading claim on its label that it treats ‘disorders of menstrual flow’, which is a contravention of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.

Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 prohibits advertisement of certain drugs for treatment of certain diseases and disorders. No person shall take part in publication of advertisement regarding the diseases/disorders indicated under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.

During the special raids conducted on 30th April and 1st May, officials from the Drugs Control Administration, Hyderabad Zone, detected ‘Colinol-SPAS Tablets’ (Mefenamic Acid and Dicyclomine Hydrochloride Tablets IP) Manufactured and Marketed by: Vivimed Labs Ltd., Plot No. 25, Kundeshwari Village, Kashipur- 244713, Uttarakhand. The label of the product bears a misleading claim stating that it is indicated for the treatment of ‘spasmodic dysmenorrhea, menstrual disorders.’

The advertisement of a medicine for the treatment of ‘disorders of menstrual flow’ is prohibited under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954. P. Santosh, Drugs Inspector, Mehdipatnam and V. Ajay, Drugs Inspector, Goshamahal are among the officers who carried out the raid. Further investigation shall be carried out and action shall be taken as per the law against all the offenders.

The public may report any complaints regarding illegal activities concerning medicines through the Drugs Control Administration, Telangana Toll-Free Number 1800-599-6969, which is operational from 10:30 am to 5:00 pm on all working days.

Related Posts

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

New Delhi: The entry of semaglutide generics in India is ‘stimulating’ market growth and providing a favourable push to Eli Lilly’s blockbuster brand Mounjaro (tirzepatide), said Patrik Jonsson, Executive Vice…

Pak-made illegal cosmetics recovered from Itwari shop

Nagpur: Maharashtra Food and Drug Administration (FDA), Nagpur Division, raided a cosmetics firm in Itwari market and seized Pakistan-origin beauty products suspected to have harmful mercury and steroids last week. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Pak-made illegal cosmetics recovered from Itwari shop

Pak-made illegal cosmetics recovered from Itwari shop

Licences of 20 medical stores suspended after inspections

Licences of 20 medical stores suspended after inspections

Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

HP accounts for 47 inferior drugs in March alert

HP accounts for 47 inferior drugs in March alert